Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
61.417,01
0,86%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Yumanity Therapeutics Inc (YMTX) Yumanity Therapeutics Inc (YMTX) Notizie

YMTX

Yumanity Therapeutics (YMTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:YMTX
DataOraFonteTitoloSimboloCompagnia
16/12/202220:58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:YMTXYumanity Therapeutics Inc
16/12/202216:38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:YMTXYumanity Therapeutics Inc
15/12/202212:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMTXYumanity Therapeutics Inc
06/12/202222:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:YMTXYumanity Therapeutics Inc
05/12/202213:30GlobeNewswire Inc.Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMTXYumanity Therapeutics Inc
14/11/202214:16GlobeNewswire Inc.Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
14/11/202212:09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222:27Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:YMTXYumanity Therapeutics Inc
10/11/202222:15GlobeNewswire Inc.Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.NASDAQ:YMTXYumanity Therapeutics Inc
04/11/202221:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:YMTXYumanity Therapeutics Inc
29/08/202212:30GlobeNewswire Inc.Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with KinetaNASDAQ:YMTXYumanity Therapeutics Inc
04/08/202222:15GlobeNewswire Inc.Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
06/06/202212:30GlobeNewswire Inc.Yumanity Therapeutics Announces Definitive Agreements for Two Strategic TransactionsNASDAQ:YMTXYumanity Therapeutics Inc
12/05/202222:45GlobeNewswire Inc.Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
25/04/202222:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMTXYumanity Therapeutics Inc
25/04/202222:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202221:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:YMTXYumanity Therapeutics Inc
24/03/202221:15GlobeNewswire Inc.Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMTXYumanity Therapeutics Inc
17/02/202214:30GlobeNewswire Inc.Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces RestructuringNASDAQ:YMTXYumanity Therapeutics Inc
14/02/202223:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:YMTXYumanity Therapeutics Inc
05/02/202200:48GlobeNewswire Inc.Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:YMTXYumanity Therapeutics Inc
19/01/202213:30GlobeNewswire Inc.Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739  NASDAQ:YMTXYumanity Therapeutics Inc
11/01/202214:00GlobeNewswire Inc.Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External CollaborationsNASDAQ:YMTXYumanity Therapeutics Inc
04/01/202214:00GlobeNewswire Inc.Yumanity Therapeutics to Present at the H.C. Wainwright BioConnect ConferenceNASDAQ:YMTXYumanity Therapeutics Inc
20/12/202122:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:YMTXYumanity Therapeutics Inc
03/12/202122:17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:YMTXYumanity Therapeutics Inc
19/11/202122:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMTXYumanity Therapeutics Inc
16/11/202122:30GlobeNewswire Inc.Yumanity Therapeutics to Present at Multiple Upcoming November Investor ConferencesNASDAQ:YMTXYumanity Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:YMTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
TRN
Terna Trasmissione Elett...
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network